1. Reddy, L.H., R. Sharma, and R. Murthy, Enhanced tumour uptake of doxorubicin loaded poly (butyl cyanoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumour. Journal of drug targeting, 2004. 12(7): p. 443-451.
2. Kim, D., et al., In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. Molecular pharmaceutics, 2009. 6(5): p. 1353-1362.
3. Bertoni, S., N. Passerini, and B. Albertini, Chapter 3 - Nanomaterials for oral drug administration, in Nanotechnology for Oral Drug Delivery, J.P. Martins and H.A. Santos, Editors. 2020, Academic Press. p. 27-76.
4. Shapira, A., et al., Beta-casein nanoparticles as an oral delivery system for chemotherapeutic drugs: impact of drug structure and properties on co-assembly. Pharmaceutical research, 2010. 27(10): p. 2175-2186.
5. Mei, L., et al., Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Advanced drug delivery reviews, 2013. 65(6): p. 880-890.
6. Huang, J., et al., Layer-by-layer assembled milk protein coated magnetic nanoparticle enabled oral drug delivery with high stability in stomach and enzyme-responsive release in small intestine. Biomaterials, 2015. 39: p. 105-113.
7. Cheewatanakornkool, K., et al., Characterization and in vitro release studies of oral microbeads containing thiolated pectin–doxorubicin conjugates for colorectal cancer treatment. asian journal of pharmaceutical sciences, 2017. 12(6): p. 509-520.
8. Ferrari, M., Cancer nanotechnology: opportunities and challenges. Nature reviews cancer, 2005. 5(3): p. 161-171.
9. Kumar, N. and R. Kumar, Chapter 4 - Nanomedicine for Cancer Treatment, in Nanotechnology and Nanomaterials in the Treatment of Life-threatening Diseases, N. Kumar and R. Kumar, Editors. 2014, William Andrew Publishing: Oxford. p. 177-246.
10. Grobmyer, S.R., B.M. Moudgil, and SpringerLink, Cancer nanotechnology : methods and protocols. 2010, New York, NY: New York, NY : Humana Press.
11. Roger, E., et al., Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine, 2010. 5(2): p. 287-306.
12. Mei, L., et al., Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev, 2013. 65(6): p. 880-90.
13. Reinholz, J., K. Landfester, and V. Mailänder, The challenges of oral drug delivery via nanocarriers. Drug delivery, 2018. 25(1): p. 1694-1705.
14. Ghosh, S., S. Ghosh, and P.C. Sil, Role of nanostructures in improvising oral medicine. Toxicology Reports, 2019. 6: p. 358-368.
15. Xu, W., P. Ling, and T. Zhang, Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs. Journal of Drug Delivery, 2013. 2013: p. 340315.
16. Lee, S.C., et al., Hydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterization. Biomacromolecules, 2007. 8(1): p. 202-208.
17. Zhang, Z., et al., A self-assembled nanocarrier loading teniposide improves the oral delivery and drug concentration in tumor. Journal of Controlled Release, 2013. 166(1): p. 30-37.
18. Mathot, F., et al., Intestinal uptake and biodistribution of novel polymeric micelles after oral administration. Journal of controlled release, 2006. 111(1-2): p. 47-55.
19. Mathot, F., et al., Transport mechanisms of mmePEG750P (CL-co-TMC) polymeric micelles across the intestinal barrier. Journal of controlled release, 2007. 124(3): p. 134-143.
20. Jain, A., et al., Formation and functional attributes of electrostatic complexes involving casein and anionic polysaccharides: An approach to enhance oral absorption of lycopene in rats in vivo. International journal of biological macromolecules, 2016. 93: p. 746-756.
21. Rehan, F., N. Ahemad, and M. Gupta, Casein Nanomicelle as an emerging biomaterial–A comprehensive review. Colloids and Surfaces B: Biointerfaces, 2019.
22. Penalva, R., et al., Casein nanoparticles as carriers for the oral delivery of folic acid. Food Hydrocolloids, 2015. 44(Supplement C): p. 399-406.
23. Głąb, T.K. and J. Boratyński, Potential of Casein as a Carrier for Biologically Active Agents. Topics in Current Chemistry, 2017. 375(4): p. 71.
24. Liu, C., et al., Self-Assembled Casein Nanoparticles Loading Triptolide for the Enhancement of Oral Bioavailability. Natural Product Communications, 2020. 15(8): p. 1934578X20948352.
25. Malekhosseini, P., et al., Development of casein‐based nanoencapsulation systems for delivery of epigallocatechin gallate and folic acid. Food science & nutrition, 2019. 7(2): p. 519-527.
26. Peñalva, R., et al., Increased oral bioavailability of resveratrol by its encapsulation in casein nanoparticles. International journal of molecular sciences, 2018. 19(9): p. 2816.
27. Semo, E., et al., Casein micelle as a natural nano-capsular vehicle for nutraceuticals. Food Hydrocolloids, 2007. 21(5): p. 936-942.
28. Shapira, A., et al., β-Casein nanoparticle-based oral drug delivery system for potential treatment of gastric carcinoma: Stability, target-activated release and cytotoxicity. European Journal of Pharmaceutics and Biopharmaceutics, 2012. 80(2): p. 298-305.
29. Esmaili, M., et al., Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin; food industry application. LWT-food science and technology, 2011. 44(10): p. 2166-2172.
30. Pan, K., Q. Zhong, and S.J. Baek, Enhanced dispersibility and bioactivity of curcumin by encapsulation in casein nanocapsules. Journal of agricultural and food chemistry, 2013. 61(25): p. 6036-6043.
31. Chen, H., Y. Zhang, and Q. Zhong, Physical and antimicrobial properties of spray-dried zein–casein nanocapsules with co-encapsulated eugenol and thymol. Journal of Food Engineering, 2015. 144(Supplement C): p. 93-102.
32. Chen, L., et al., Casein nanoparticles as oral delivery carriers of mequindox for the improved bioavailability. Colloids and Surfaces B: Biointerfaces, 2020. 195: p. 111221.
33. Elbialy, N.S. and N. Mohamed, Alginate-coated caseinate nanoparticles for doxorubicin delivery: Preparation, characterisation, and in vivo assessment. International Journal of Biological Macromolecules, 2020.
34. Hira, S.K., et al., Targeted delivery of doxorubicin-loaded poly (ε-caprolactone)-b-poly (N-vinylpyrrolidone) micelles enhances antitumor effect in lymphoma. Plos one, 2014. 9(4): p. e94309.
35. Zhang, J., et al., Cisplatin and doxorubicin high-loaded nanodrug based on biocompatible thioether-and ethane-bridged hollow mesoporous organosilica nanoparticles. Journal of colloid and interface science, 2018. 513: p. 214-221.
36. Rehan, F., et al., Optimization and Formulation of Nanostructured and Self-Assembled Caseinate Micelles for Enhanced Cytotoxic Effects of Paclitaxel on Breast Cancer Cells. Pharmaceutics, 2020. 12(10).
37. Scheeren, L.E., et al., Comparative study of reversed-phase high-performance liquid chromatography and ultraviolet–visible spectrophotometry to determine doxorubicin in pH-sensitive nanoparticles. Analytical Letters, 2018. 51(10): p. 1445-1463.
38. Elzoghby, A.O., W.M. Samy, and N.A. Elgindy, Novel spray-dried genipin-crosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride. Pharmaceutical Research, 2013. 30(2): p. 512-522.
39. Rehan, F., et al., Optimization and formulation of nanostructured and self-assembled caseinate micelles for enhanced cytotoxic effects of paclitaxel on breast cancer cells. Pharmaceutics, 2020. 12(10): p. 984.
40. Quintás, G., et al., Fourier transform infrared determination of imidacloprid in pesticide formulations. Journal of the Brazilian Chemical Society, 2004. 15(2): p. 307-312.
41. Fatemian, T. and E.H. Chowdhury, Cytotoxicity Enhancement in Breast Cancer Cells with Carbonate Apatite-Facilitated Intracellular Delivery of Anti-Cancer Drugs. Toxics, 2018. 6(1).
42. El-Far, S.W., et al., Phytosomal bilayer-enveloped casein micelles for codelivery of monascus yellow pigments and resveratrol to breast cancer. Nanomedicine (Lond), 2018. 13(5): p. 481-499.
43. Cui, C., et al., Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles. Biomaterials, 2013. 34(15): p. 3858-3869.
44. Bae, Y., et al., Design of environment‐sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change. Angewandte Chemie International Edition, 2003. 42(38): p. 4640-4643.
45. Oecd, OECD Guidelines for the Testing of Chemicals. 1994: Organization for Economic.
46. Roux, S., E. Sablé, and R.D. Porsolt, Primary observation (Irwin) test in rodents for assessing acute toxicity of a test agent and its effects on behavior and physiological function. Current Protocols in Pharmacology, 2004. 27(1): p. 10.10. 1-10.10. 23.
47. Anadón, A., et al., Acute Oral Safety Study of Sodium Caseinate Glycosylated via Maillard Reaction with Galactose in Rats. Journal of food protection, 2014. 77(3): p. 472-479.
48. Casanova, F., Colloidal stability of native and cross-linked casein micelles and their potential use as nanocarrier for cyanidin-3-0 glucoside. 2017, Universidade Federal de Viçosa.
49. Casanova, F., et al., pH-and ionic strength-dependent interaction between cyanidin-3-O-glucoside and sodium caseinate. Food chemistry, 2018. 267: p. 52-59.
50. Wang, J., et al., A micelle self-assembled from doxorubicin-arabinoxylan conjugates with ph-cleavable bond for synergistic antitumor therapy. Nanoscale Research Letters, 2017. 12(1): p. 1-9.
51. Ali, O.M., et al., Synthesis of Lactoferrin Mesoporous Silica Nanoparticles for Pemetrexed/Ellagic Acid Synergistic Breast Cancer Therapy. Colloids and Surfaces B: Biointerfaces, 2020: p. 110824.
52. Shi, P. and J.C. Goh, Release and cellular acceptance of multiple drugs loaded silk fibroin particles. International journal of pharmaceutics, 2011. 420(2): p. 282-289.
53. Jain, S., et al., pH dependent drug release from drug conjugated PEGylated CdSe/ZnS nanoparticles. Materials Chemistry and Physics, 2020. 240: p. 122162.
54. Victor, S.P., et al., Supramolecular hydroxyapatite complexes as theranostic near-infrared luminescent drug carriers. CrystEngComm, 2014. 16(38): p. 9033-9042.
55. Gnapareddy, B., et al., Chemical and physical characteristics of doxorubicin hydrochloride drug-doped salmon DNA thin films. Scientific reports, 2015. 5: p. 12722.
56. Gandhi, S. and I. Roy, Doxorubicin-loaded casein nanoparticles for drug delivery: Preparation, characterization and in vitro evaluation. International journal of biological macromolecules, 2019. 121: p. 6-12.
57. Elzoghby, A.O., et al., Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics. International journal of nanomedicine, 2013. 8: p. 1721.
58. Raj, J. and K.B. Uppuluri, Metformin loaded casein micelles for sustained delivery: formulation, characterization and in-vitro evaluation. Biomedical and Pharmacology Journal, 2015. 8(1): p. 83-89.
59. Abdelmoneem, M.A., et al., Dual-targeted casein micelles as green nanomedicine for synergistic phytotherapy of hepatocellular carcinoma. Journal of Controlled Release, 2018. 287: p. 78-93.
60. Liu, J., et al., Combining spatially resolved hydrochemical data with in-vitro nanoparticle stability testing: Assessing environmental behavior of functionalized gold nanoparticles on a continental scale. Environment International, 2013. 59: p. 53-62.
61. Hossain, S., et al., Fabrication and intracellular delivery of doxorubicin/carbonate apatite nanocomposites: effect on growth retardation of established colon tumor. PLoS One, 2013. 8(4): p. e60428.
62. Tang, L., et al., Targeting tumor vasculature with aptamer-functionalized doxorubicin–polylactide nanoconjugates for enhanced cancer therapy. ACS nano, 2015. 9(5): p. 5072-5081.
63. Chaudhary, A., et al., One pot synthesis of doxorubicin loaded gold nanoparticles for sustained drug release. RSC Advances, 2015. 5(118): p. 97330-97334.
64. Kataoka, K., et al., Doxorubicin-loaded poly (ethylene glycol)–poly (β-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. Journal of Controlled Release, 2000. 64(1-3): p. 143-153.
65. Amjad, M.W., et al., Doxorubicin-loaded cholic acid-polyethyleneimine micelles for targeted delivery of antitumor drugs: synthesis, characterization, and evaluation of their in vitro cytotoxicity. Nanoscale Research Letters, 2012. 7(1): p. 687.
66. Sun, C.Z., et al., Characterization of the doxorubicin-pluronic F68 conjugate micelles and their effect on doxorubicin resistant human erythroleukemic cancer cells. Journal of Nanomedicine and Nanotechnology, 2011. 2: p. 1000114.
67. Bakhtiar, A. and E.H. Chowdhury, PH-responsive strontium nanoparticles for targeted gene therapy against mammary carcinoma cells. Asian journal of pharmaceutical sciences, 2021. 16(2): p. 236-252.
68. El-Far, S.W., et al., Phytosomal bilayer-enveloped casein micelles for codelivery of monascus yellow pigments and resveratrol to breast cancer. Nanomedicine, 2018. 13(5): p. 481-499.
69. Mohapatra, S., et al., Doxorubicin loaded carboxymethyl Assam bora rice starch coated superparamagnetic iron oxide nanoparticles as potential antitumor cargo. Heliyon, 2019. 5(6): p. e01955.
70. Picchio, M.L., et al., Crosslinked casein-based micelles as a dually responsive drug delivery system. Polymer Chemistry, 2018. 9(25): p. 3499-3510.
71. Komuro, H., et al., The effect of glucose modification of hydroxyapatite nanoparticles on gene delivery. Journal of Biomedical Materials Research Part A, 2019. 107(1): p. 61-66.
72. Chowdhury, E.H., Nanotherapeutics: from laboratory to clinic. 2016: CRC press.
73. Swarnakar, N.K., K. Thanki, and S. Jain, Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity. Pharmaceutical research, 2014. 31(5): p. 1219-1238.
74. Kanwal, U., et al., Advances in nano-delivery systems for doxorubicin: an updated insight. Journal of Drug Targeting, 2018. 26(4): p. 296-310.
75. Souris, J.S., et al., Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials, 2010. 31(21): p. 5564-5574.
76. Ambruosi, A., H. Yamamoto, and J. Kreuter, Body distribution of polysorbate‐80 and doxorubicin-loaded [14C] poly (butyl cyanoacrylate) nanoparticles after iv administration in rats. Journal of drug targeting, 2005. 13(10): p. 535-542.
77. Perlstein, H., et al., Beta-casein nanocarriers of celecoxib for improved oral bioavailability. European Journal of Nanomedicine, 2014. 6(4): p. 217-226.
78. Bar-Zeev, M., Y.G. Assaraf, and Y.D. Livney, β-casein nanovehicles for oral delivery of chemotherapeutic drug combinations overcoming P-glycoprotein-mediated multidrug resistance in human gastric cancer cells. Oncotarget, 2016. 7(17): p. 23322.
79. Lee, M.-Y., et al., A 4-week repeated dose oral toxicity and cytotoxicity study of gumiganghwaltang in Crl: CD (SD) rats. Toxicology international, 2011. 18(2): p. 146.
80. Kim, J.-C., et al., Subchronic toxicity of plant sterol esters administered by gavage to Sprague–Dawley rats. Food and chemical toxicology, 2002. 40(11): p. 1569-1580.